GPER1 and neoplasm: Estrogen receptors (ERs), such as nuclear ERα and ERβ, and G protein-coupled estrogen receptor (GPER), are aberrantly expressed in a wide variety of malignancies other than estrogen-related cancers, and ERβ expression has been reported to decline in tumor tissues compared with normal tissues (3–6).